Update on Clinical Trials as Prior Art against Pharma Patent in Europe
Chemistry Partner Dr. Holger Tostmann will present at the AIPLA Spring meeting (mid-May) on the increasingly important role of clinical trials as prior art against patents of the sponsors of these clinical trials. Both clinical trial documentation that has to be made public via an EU-wide clinical…
read